Traders Purchase Large Volume of Enovix Call Options (NASDAQ:ENVX)

Enovix Co. (NASDAQ:ENVXGet Free Report) was the recipient of unusually large options trading on Thursday. Stock investors acquired 31,902 call options on the stock. This is an increase of 60% compared to the average volume of 19,932 call options.

Enovix Trading Up 10.6 %

Enovix stock opened at $6.46 on Friday. Enovix has a fifty-two week low of $5.70 and a fifty-two week high of $23.90. The firm has a fifty day moving average price of $8.18 and a two-hundred day moving average price of $10.11. The company has a debt-to-equity ratio of 0.65, a current ratio of 5.30 and a quick ratio of 5.15.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.01). Enovix had a negative net margin of 2,800.51% and a negative return on equity of 77.74%. The business had revenue of $7.38 million during the quarter, compared to the consensus estimate of $3.37 million. On average, research analysts anticipate that Enovix will post -1.13 EPS for the current year.

Insiders Place Their Bets

In other news, COO Ajay Marathe sold 4,954 shares of Enovix stock in a transaction that occurred on Sunday, April 14th. The shares were sold at an average price of $7.31, for a total value of $36,213.74. Following the completion of the transaction, the chief operating officer now owns 978,913 shares in the company, valued at $7,155,854.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ENVX. DnB Asset Management AS acquired a new position in Enovix during the third quarter worth $790,000. SG Americas Securities LLC grew its stake in Enovix by 106.4% in the 3rd quarter. SG Americas Securities LLC now owns 17,953 shares of the company’s stock worth $225,000 after buying an additional 9,253 shares in the last quarter. DDD Partners LLC lifted its position in Enovix by 106.5% during the third quarter. DDD Partners LLC now owns 30,035 shares of the company’s stock valued at $377,000 after buying an additional 15,490 shares during the period. Handelsbanken Fonder AB lifted its position in shares of Enovix by 0.4% during the 3rd quarter. Handelsbanken Fonder AB now owns 2,622,620 shares of the company’s stock valued at $32,914,000 after buying an additional 9,800 shares in the last quarter. Finally, U.S. Capital Wealth Advisors LLC bought a new position in Enovix in the 3rd quarter valued at $153,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on ENVX. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price target on shares of Enovix in a research note on Thursday. JPMorgan Chase & Co. decreased their price objective on Enovix from $18.00 to $12.00 and set an “overweight” rating for the company in a research note on Friday. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price objective on shares of Enovix in a research report on Wednesday, February 21st. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.43.

Get Our Latest Stock Report on Enovix

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.